KB Pharm is preparing for
the upcoming future with

enhanced human health and better life.

Korea’s No. 1 Research Center
for researching and developing APIs medicines

We continue to innovate our research
center with our specialty with the aim to
become a leading global research center.

General active pharmaceutical ingredients

General APIs Plant 1 and 3

Active pharmaceutical ingredients for
cephalosporin drugs / injectable intermediates

General APIs Plant 2

Finished Solid oral dosage form drugs

Solid Oral Dosage Form Plant

Anticancer, High Potency APIs

Synthetic APIs Plants 4, 5

Active pharmaceutical ingredients for
carbapenem and cephalosporin injectable drugs

Sterile APIs Plants 1 and 2

Finished cephalosporin injectable drugs

Sterile Medical Vials Plant

Since KB Pharm founded its Research Center in 1988, they have been
developing top-notch APIs medicines based on decades of experience.
Detail view

KB Pharm delivers
love and sharing. Direct link to Social Contribution

Residential environment

We visit the homes of people in need and replace
their wallpapers and floorings to improve their living

Nursing Home Visits

We pay visits to nursing homes and assist in bathing, entertaining,
and feeding senior citizens with limited mobility.


We adopt rivers nearby our places of business
and look after them to preserve their ecosystems
and the quality of the water in those rivers.

Leading Innovative
Pharma-Chemical Player

KB Pharm will grow to become a leader in
the global pharmaceutical-based chemical
industry beyond Korea’s top and
largest API companies.


[Head Office(Asan)] 174, Sirok-ro, Asan-si, Chungcheongnam-do, Korea

[Seoul Office] 4th floor, Chong Kun Dang Building, Chungjeong-ro 8 (Chungjeong-ro 3-ga), Seodaemun-gu, Seoul





Ⓒ Copyright 2019 Kyongbo Pharm All Rights Reserved


         위해 의약품등 회수에 관한 공표

                              (의약품, 2등급 위해성)

         약사법 제72조의 규정에 의하여 아래의 의약품 등을 긴급 회수함을 공표합니다


 가. 회수제품명: 졸레론주사액5밀리그램/100밀리리터(졸레드론산일수화물), 포장단위: 100mL/

 나. 제조일자 / 유효기간 : 2021.11.24 / 2023.11.23

 다. 제조번호: AC001

 라. 회수사유: 유연물질 증가로 인한 위해 발생 우려에 따른 사전 예방적 조치

 마. 회수방법: 취급 판매업소 및 의료기관별 방문하여 도매업소 교환 수거

 바. 회수영업자: ㈜경보제약 (대표자 김태영)

 사. 영업자주소: 충청남도 아산시 실옥로 174

 아. 연락처: TEL) 02-365-2312, FAX) 02-2175-2395

 자: 자료작성년월일: 2022. 05. 23.


  ※ 당해 회수대상 의약품 등을 보관하고 있는 판매업소 및 의료기관에서는 즉시 판매를 중지하고

     회수영업자에게 반품하여 주시기 바랍니다.